Walmart agreed to pay $50 million to settle a U.S. Department of Justice lawsuit alleging its pharmacies unlawfully dispensed opioid prescriptions. The settlement, confirmed on August 28, is far below the billions in penalties the DOJ had originally sought. Walmart did not admit liability and described the amount as immaterial. The agreement also requires the company to tighten pharmacist oversight and implement a DEA-monitored compliance program.
- Walmart settled a DOJ lawsuit over unlawful opioid dispensing at its pharmacies since 2013 for $50 million.
- The settlement amount is far below the billions originally sought by the DOJ, and Walmart called it immaterial.
- The agreement mandates tighter pharmacist oversight and a DEA-monitored compliance program at Walmart.